Halil I. Ciftci

Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors

Belgin Sever, Mehlika Dilek Altıntop, Mohamed O. Radwan et al. · European Journal of Medicinal Chemistry · 2019 · 115 citations · Full text

Medicinal Chemistry, Her2 Inhibitors, Biochemistry +10

Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents

Muhammed Karabacak, Mehlika Dilek Altıntop, Halil I. Ciftci et al. · Molecules · 2015 · 103 citations · Full text

Bioorganic Chemistry, Chemoprevention Strategy, Pharmacotherapy +21

Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety

Mehlika Dilek Altıntop, Halil I. Ciftci, Mohamed O. Radwan et al. · Molecules · 2017 · 69 citations · Full text

A clue to unprecedented strategy to HIV eradication: “Lock-in and apoptosis”

Hiroshi Tateishi, Kazuaki Monde, Kensaku Anraku et al. · Scientific Reports · 2017 · 50 citations · Full text

The First Pentacyclic Triterpenoid Gypsogenin Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia Activities

Halil I. Ciftci, Safiye Emirdağ, Taha F. S. Ali et al. · Biological and Pharmaceutical Bulletin · 2018 · 48 citations · Full text

Mixed-phenotype Acute Leukemia, Compound 1C, Pharmacotherapy +18